Lipid exchange of apolipoprotein A-I amyloidogenic variants in reconstituted high-density lipoprotein with artificial membranes

被引:1
|
作者
Correa, Yubexi [1 ,2 ]
Ravel, Mathilde [1 ,2 ]
Imbert, Marie [1 ,2 ]
Waldie, Sarah [1 ,2 ]
Clifton, Luke [3 ]
Terry, Ann [4 ]
Roosen-Runge, Felix [1 ,2 ]
Lagerstedt, Jens O. [5 ,6 ]
Moir, Michael [7 ]
Darwish, Tamim [7 ,8 ]
Cardenas, Marite [1 ,2 ,9 ,10 ,11 ]
Del Giudice, Rita [1 ,2 ,12 ]
机构
[1] Malmo Univ, Biofilm Res Ctr Biointerfaces, Malmo, Sweden
[2] Malmo Univ, Fac Hlth & Soc, Dept Biomed Sci, Malmo, Sweden
[3] Harwell Sci & Innovat Campus, Sci & Technol Facil Council, Rutherford Appleton Lab, ISIS Pulsed Neutron & Muon Source, Didcot, England
[4] Lund Univ, MAX Lab 4, CoSAXS Beamline, Lund, Sweden
[5] Lund Univ, Diabet Ctr, Dept Clin Sci Malmo, Islet Cell Exocytosis, Malmo, Sweden
[6] Novo Nordisk, Rare Endocrine Disorders, Res & Early Dev, Copenhagen, Denmark
[7] Australian Nucl Sci & Technol Org ANSTO, Natl Deuterat Facil, Lucas Heights, NSW, Australia
[8] Univ Canberra, Fac Sci & Technol, Canberra, ACT, Australia
[9] Basque Fdn Sci, Ikerbasque, Bilbao, Spain
[10] Univ Basque Country, Biofis Inst, Leioa, Spain
[11] Malmo Univ, Biofilm Res Ctr Biointerfaces, S-20506 Malmo, Sweden
[12] Malmo Univ, Fac Hlth & Soc, Dept Biomed Sci, S-20506 Malmo, Sweden
关键词
amyloidogenic variants; apolipoprotein A-I; high-density lipoprotein; reconstituted HDL; X-RAY-SCATTERING; APOA-I; CHOLESTEROL; BILAYERS; ACID; CONFORMATIONS; MODEL; ORGANIZATION; BIOGENESIS; THERAPIES;
D O I
10.1002/pro.4987
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High-density lipoproteins (HDLs) are responsible for removing cholesterol from arterial walls, through a process known as reverse cholesterol transport. The main protein in HDL, apolipoprotein A-I (ApoA-I), is essential to this process, and changes in its sequence significantly alter HDL structure and functions. ApoA-I amyloidogenic variants, associated with a particular hereditary degenerative disease, are particularly effective at facilitating cholesterol removal, thus protecting carriers from cardiovascular disease. Thus, it is conceivable that reconstituted HDL (rHDL) formulations containing ApoA-I proteins with functional/structural features similar to those of amyloidogenic variants hold potential as a promising therapeutic approach. Here we explored the effect of protein cargo and lipid composition on the function of rHDL containing one of the ApoA-I amyloidogenic variants G26R or L174S by Fourier transformed infrared spectroscopy and neutron reflectometry. Moreover, small-angle x-ray scattering uncovered the structural and functional differences between rHDL particles, which could help to comprehend higher cholesterol efflux activity and apparent lower phospholipid (PL) affinity. Our findings indicate distinct trends in lipid exchange (removal vs. deposition) capacities of various rHDL particles, with the rHDL containing the ApoA-I amyloidogenic variants showing a markedly lower ability to remove lipids from artificial membranes compared to the rHDL containing the native protein. This effect strongly depends on the level of PL unsaturation and on the particles' ultrastructure. The study highlights the importance of the protein cargo, along with lipid composition, in shaping rHDL structure, contributing to our understanding of lipid-protein interactions and their behavior.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Neutrophil Activation Is Attenuated by High-Density Lipoprotein and Apolipoprotein A-I in In Vitro and In Vivo Models of Inflammation
    Murphy, Andrew J.
    Woollard, Kevin J.
    Suhartoyo, Andreas
    Stirzaker, Roslynn A.
    Shaw, James
    Sviridov, Dmitri
    Chin-Dusting, Jaye P. F.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (06) : 1333 - U221
  • [22] Apolipoprotein A-I Inhibits Transendothelial Transport of Apolipoprotein B-Carrying Lipoproteins and Enhances Its Associated High-Density Lipoprotein Formation
    Guo, Zhongmao
    Zhang, Ningya
    Yang, Hong
    JOURNAL OF VASCULAR RESEARCH, 2022, 59 (05) : 275 - 287
  • [23] Apolipoprotein A-I structure in high-density lipoproteins
    Silva, R. A. Gangani D.
    Tubb, Matthew R.
    Davidson, W. Sean
    ANNALS OF MEDICINE, 2008, 40 : 5 - 13
  • [24] Tertiary structure of apolipoprotein A-I in nascent high-density lipoproteins
    Pourmousa, Mohsen
    Song, Hyun D.
    He, Yi
    Heinecke, Jay W.
    Segrest, Jere P.
    Pastor, Richard W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (20) : 5163 - 5168
  • [25] The relationship between serum amyloid A and apolipoprotein A-I in high-density lipoprotein isolated from patients with coronary heart disease
    Wang Dong-xue
    Liu Hong
    Yan Li-rong
    Zhang Ye-ping
    Guan Xiao-yuan
    Xu Zhi-min
    Jia You-hong
    Li Yi-shi
    CHINESE MEDICAL JOURNAL, 2013, 126 (19) : 3656 - 3661
  • [26] High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies
    Ooi, E. M. M.
    Watts, G. F.
    Farvid, M. S.
    Chan, D. C.
    Allen, M. C.
    Zilko, S. R.
    Barrett, P. H. R.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (09) : 626 - 632
  • [27] High-Density Lipoprotein Biogenesis: Defining the Domains Involved in Human Apolipoprotein A-I Lipidation
    Pollard, Ricquita D.
    Fulp, Brian
    Sorci-Thomas, Mary G.
    Thomas, Michael J.
    BIOCHEMISTRY, 2016, 55 (35) : 4971 - 4981
  • [28] The roles of C-terminal helices of human apolipoprotein A-I in formation of high-density lipoprotein particles
    Nagao, Kohjiro
    Hata, Mami
    Tanaka, Kento
    Takechi, Yuki
    Nguyen, David
    Dhanasekaran, Padmaja
    Lund-Katz, Sissel
    Phillips, Michael C.
    Saito, Hiroyuki
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2014, 1841 (01): : 80 - 87
  • [29] Comparison of Mechanisms of Endothelial Cell Protections Between High-Density Lipoprotein and Apolipoprotein A-I Mimetic Peptide
    Xu, Wenqi
    Qian, Mingming
    Huang, Caihua
    Cui, Pengfei
    Li, Wei
    Du, Qian
    Yi, Shenghui
    Shi, Xiaohe
    Guo, Yansong
    Zheng, Jianlan
    Liu, Donghui
    Lin, Donghai
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [30] Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production
    Franssen, Remco
    Sankatsing, Raaj R.
    Hassink, Elly
    Hutten, Barbara
    Ackermans, Mariette T.
    Brinkman, Kees
    Oesterholt, Rene
    Arenas-Pinto, Alejandro
    Storfer, Stephen P.
    Kastelein, John J.
    Sauerwein, Hans P.
    Reiss, Peter
    Stroes, Erik S.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (09) : 1336 - 1341